Glenn Waller Selected Research

Feeding and Eating Disorders (Eating Disorder)

11/2021	New developments in cognitive-behavioural therapy for eating disorders (CBT-ED).
1/2021	The costs and benefits of intensive day treatment programs and outpatient treatments for eating disorders: An idea worth researching.
11/2020	Outcomes of brief and enhanced cognitive-behavioural therapy for adults with non-underweight eating disorders: A non-randomized comparison.
1/2020	Cognitive-behavioral therapy in the time of coronavirus: Clinician tips for working with eating disorders via telehealth when face-to-face meetings are not possible.
1/2019	Predictors of outcome in cognitive behavioural therapy for eating disorders: An exploratory study.
1/2019	Alliance, technique, both, or more? Clinicians' views on what works in cognitive-behavioral therapy for eating disorders.
1/2019	A pragmatic effectiveness study of 10-session cognitive behavioural therapy (CBT-T) for eating disorders: Targeting barriers to treatment provision.
1/2019	The Modum-ED Trial Protocol: Comparing Compassion-Focused Therapy and Cognitive-Behavioral Therapy in Treatment of Eating Disorders With and Without Childhood Trauma: Protocol of a Randomized Trial.
1/2019	Do eating disorder voice characteristics predict treatment outcomes in anorexia nervosa? A pilot study.
1/2019	Optimizing treatment outcomes in adolescents with eating disorders: The potential role of cognitive behavioral therapy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Glenn Waller Research Topics

Disease

29	Feeding and Eating Disorders (Eating Disorder) 11/2021 - 04/2006
7	Anorexia Nervosa 01/2021 - 03/2003
3	Personality Disorders (Personality Disorder) 01/2021 - 03/2014
2	Schizophrenia (Dementia Praecox) 01/2021 - 11/2018
2	Binge-Eating Disorder (Binge Eating Disorder) 11/2020 - 11/2020
2	Bulimia Nervosa 11/2020 - 12/2004
2	Weight Gain 05/2013 - 09/2012
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2021
1	Psychotic Disorders (Schizoaffective Disorder) 11/2018
1	Bulimia (Binge Eating) 01/2017
1	Alcoholism (Alcohol Abuse) 01/2007
1	Substance-Related Disorders (Drug Abuse) 01/2007
1	Borderline Personality Disorder (Personality Disorders, Borderline) 03/2001

Drug/Important Bio-Agent (IBA)

4	ElementsIBA 01/2021 - 04/2006
1	Pharmaceutical PreparationsIBA 01/2021
1	Antipsychotic Agents (Antipsychotics)IBA 11/2018
1	Indicators and Reagents (Reagents)IBA 01/2012
1	Cocaine (Cocaine HCl)IBA 01/2007
1	AmphetaminesIBA 01/2007
1	Ketamine FDA LinkGeneric 01/2007
1	BenzodiazepinesIBA 01/2007
1	DNA Transposable Elements (Element, IS)IBA 12/2004
1	Flavin-Adenine Dinucleotide (FAD)IBA 03/2003

Therapy/Procedure

31	Therapeutics 11/2021 - 03/2001
1	Ambulatory Care (Outpatient Care) 01/2021
1	Transjugular Intrahepatic Portasystemic Shunt 01/2020
1	Aftercare (After-Treatment) 01/2018
1	Duration of Therapy 01/2017